Maxim Group analyst Naz Rahman maintained a Buy rating on NexGel Inc (NXGL – Research Report) yesterday and set a price target of $5.00. The company’s shares opened today at $1.50.
Rahman covers the Healthcare sector, focusing on stocks such as Viking Therapeutics, Quoin Pharmaceuticals, and scPharmaceuticals. According to TipRanks, Rahman has an average return of -11.1% and a 33.01% success rate on recommended stocks.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for NexGel Inc with a $5.00 average price target.
See today’s best-performing stocks on TipRanks >>
The company has a one-year high of $2.68 and a one-year low of $1.09. Currently, NexGel Inc has an average volume of 42.6K.
Based on the recent corporate insider activity of 13 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of NXGL in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
NexGel Inc is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics.
Read More on NXGL:
